跳至主要内容
临床试验/ACTRN12617000809336
ACTRN12617000809336已完成4 期

A Prospective Study on the Effect of Nicotinamide Supplementation on Ocular Function and Structure in Glaucoma

Centre for Eye Research Australia0 个研究点目标入组 60 人开始时间: 2017年6月2日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Diagnosis of primary open angle glaucoma by an ophthalmologist
  • - Recent (last 6 months), reliable visual field with mean defect equal to or better than -6 dB

排除标准

  • - those who are currently or intending to be pregnant/breastfeeding during the study
  • - those unwilling to abstain from other vitamin B supplements during the study period
  • - history of severe allergies or allergic reaction to nicotinamide or niacin
  • - those diagnosed with cancer in the last 5 years (except treated basal or squamous cell carcinoma)
  • - those with a history of liver disease
  • - those who cannot commit to the follow-up visits which occur at 6-weekly intervals over 24 weeks
  • - those who cannot provide informed consent
  • - eyes with a history of intraocular surgery in the past 6 months (uncomplicated cataract surgery within the last 3 months)
  • - systemic/ocular disease that are known to affect retinal function (e.g. age-related macular degeneration, demyelinating diseases, diabetic retinopathy)

研究者

相似试验

The Effect of Vitamin B3 Supplementation in Glaucoma | 临床试验